Biosig ceo kenneth l. londoner to present at the sidoti winter 2021 investor conference

Westport, ct, jan. 06, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that kenneth l. londoner, chairman and ceo of biosig technologies, inc. will be presenting live to a virtual audience at the sidoti winter 2021 investor conference on wednesday, january 13, 2021  at 2:30 pm et.
BSGM Ratings Summary
BSGM Quant Ranking